Vir Biotechnology, Inc. VIR Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s investing cash flow?
- Vir Biotechnology, Inc. (VIR) reported investing cash flow of $11.84M in Q1 2026.
- How has Vir Biotechnology, Inc.'s investing cash flow changed year-over-year?
- Vir Biotechnology, Inc.'s investing cash flow decreased by 90.7% year-over-year, from $126.82M to $11.84M.
- What is the long-term trend for Vir Biotechnology, Inc.'s investing cash flow?
- Over 3 years (2021 to 2025), Vir Biotechnology, Inc.'s investing cash flow has grown at a 30.1% compound annual growth rate (CAGR), from -$140.81M to $310.37M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.